• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1994 Fiscal Year Final Research Report Summary

ENDOTHELIN-1 IS AN AUTOCRINE GROWTH FACTOR FOR HEPATOCELLULAR CARCINO

Research Project

Project/Area Number 05454324
Research Category

Grant-in-Aid for General Scientific Research (B)

Allocation TypeSingle-year Grants
Research Field 内分泌・代謝学
Research InstitutionTeikyo University

Principal Investigator

ISHIBASHI Miyuki  Teikyo University, Medicine, Professor, 医学部, 教授 (50134599)

Co-Investigator(Kenkyū-buntansha) SUMINAGA Masasi  Teikyo University, Medicine, Research Associate, 医学部, 助手 (30163059)
Project Period (FY) 1993 – 1994
Keywordsendothelin / growth factor / hepatocellular carcinoma / tomor growth / endothelin receptor / autocrine growth factor / receptor antagonist
Research Abstract

To test the hypothesis that endothelin-1 (ET-1) may be an autocrine or paracrine growth factor for hepatocellular carcinoma (HCC), we examined the in vitro production and secretion of ET-1 by human HCC cell lines and ET-1 receptors on those cells, and studied the effect of ET-1 and/or specific ET receptor antagonists on HCC growth. Northern blot analysis demonstrated the expression of mRNA for ET-1 precursor in HCC cell lines and a substantial amount of ET-1 as determined by a specific enzyme immunoassay was found both in cell extracts and in culture media. Immunohistochemistry of HCC cells showed HCC cells positive for ET-1. When HCC cells were grown in semi-solid medium containing ET-1, ET-1 markedly increased colony growth of these HCC cell lines in a dose-dependent manner. When 10 ^6M BQ-123, a specific ET receptor antagonist, was coincubated, the stimulatory effect of 10 ^8M ET-1 on the growth of HCC cells was completely blocked. Furthermore, colony formation of Mahlavu and Alexan … More der cells was significantly inhibited by incubation with BQ-123 or the monoclonal antibody for ET-1 alone. Northern blot analysis demonstrated the expression of mRNA for human ET_B receptor in at least two HCC cell lines, Mahlavu and Hep G2. The ET_A receptor mRNA was not expressed in any of the HCC cell lines examined. A binding study conducted using a labeled endothelin as a ligand showed high affinity binding sites on Huh-7 cells (Kd=2.7 x 10 ^<10>M). To determine whether HCC growth may be ET-dependent then, two HCC cell lines, Mahlavu and Huh-7, were implanted into athymic nude mice. Administration of bosentan (10 mg/kg/day) caused a significant inhibition of tumor growth in both experiments. These results indicate that ET-1 is produced and secreted by HCC,which stimulates its own growth, and that HCC cells are enriched with ET_B receptors, which may mediate the growth-stimulatory effect of ET-1 on HCC.We conclude that ET-1 is a growth factor for HCC,and that ET receptor antagonists may be useful in the medical treatment of HCC. Less

  • Research Products

    (21 results)

All Other

All Publications (21 results)

  • [Publications] Yamaji T,Johshita H,Ishibashi M,Takaku F,Ohno H,Suzuki N,Matsumoto H,Fujino M: "Endothelin family in human plasma and cerebrospinal fluid." J Clin Endocrinol Metab. 71. 1611-1615 (1990)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kamoi K,Sudo N,Ishibashi M,Yamaji T: "Plasma endothelin-1 levels in patients with preqnancy-induced hypertension." N Engl J Med. 323. 1486-1487 (1990)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ishibashi M,Saito K,Watanabe K,Uesugi S,Furue H,Yamaji T :"Plasma endothelin-1 levels in patients with disseminated intravascular coagulation." N Engl J Med. 324. 1516-1517 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kamoi K,Ishibashi M,Yamaji T: "Plasma endothelin-1 levels in patients with hyponatremia." Nephron. 62. 469-470 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ishibashi M,Haizuka H,Tsukamura T,Furue H,Yamaji T :"Endothelin-1 and Blood Pressure." Am J Hypert. 5. 772-774 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ishibashi M,Fujita M,Nagai K,Kako K,Furue H,Haku E,Osamura Y,Yamaji T: "Production and secretion of endothelin by hepatocellular carcinama." J Clin Endocrinol Metab. 76. 378-383 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sudo N,Kamoi K,Ishibashi M,Yamaji T: "Plasma endothelin-1 and big endothelin-1 levels in women with pre-eclampsia." Acta Endocrinol. 129. 114-120 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kamoi K,Ishibashi M,Yamaji T: "Endothelin-1 and big endothelin-1 in NIDDM patients with and without microangiopathy." Diabetes Res Clin Pract. 284. 125-129 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ishibashi M,Ito N,Fujita M,Furue H,Yamaji T: "Endothelin-1 as an aggravating factor of disseminated intravascular coagulation associated with malignant neoplasms." Cancer. 73. 191-195 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ishibashi M,Fujisawa M,Furue H,Maeda Y,Fukayama M,Yamaji T: "Inhibition of growth of human small cell lung cancer by bromocriptine." Cancer Res. 54. 3442-3446 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 石橋みゆき,古江 尚,大西 真,三浦英明,藤沢道夫,岡 輝明,山路 徹: "成長因子としてのエンドセリン." 成長科学協会研究年報. 17. 343-354 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yamaji T,Johshita H,Ishibashi M,Takaku F,Ohno H,Suzuki N,Matsumoto H,Fujino M: "Endothelin family in human plasma and cerebrospinal fluid." J Clin Endocrinol Metab. 71. 1611-1615 (1990)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kamoi K,Sudo N,Ishibashi M,Yamaji T: "Plasma endothelin-1 levels in patients with pregnancy-induced hypertension." N Eng1 J Med. 323. 1486-1487 (1990)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ishibashi M,Saito K,Watanabe K,Uesugi S,Furue H,Yamaji T: "Plasma endothelin-1 levels in patients with disseminated intravascular coagulation." N Eng1 J Med. 324. 1516-1517 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kamoi K,Ishibashi M,Yamaji T: "Plasma endothelin-1 levels in patients with hyponatremia." Nephron. 62. 469-470 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ishibashi M,Haizuka H,Tsukamura T,Furue H,Yamaji T: "Endothelin-1 and Blood Pressure." Am J Hypert. 5. 772-774 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ishibashi M,Fujita M,Nagai K,Kako K,Furue H,Kaku E,Osamura Y,Yamaji T: "Production and secretion of endothelin by hepatocellular carcinoma." J Clin Endocrinol Metab. 76. 378-383 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sudo N,Kamoi K,Ishibashi M,Yamaji T: "Plasma endothelin-1 and big endothelin-1 levels in women with pre-eclampsia." Acta Endocrinol. 129. 114-120 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kamoi K,Ishibashi M,Yamaji T: "Endothelin-1 and big endothelin-1 in NIDDM patients with and without microangiopathy." Diabetes Res Clin Pract. 284. 125-129 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ishibashi M,Ito N,Fujita M,Furue H,Yamaji T: "Endothelin-1 as an aggravating factor of disseminated intravascular coagulation associated with malignant neoplasms." Cancer. 73. 191-195 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ishibashi M,Fujisawa M,Furue H,Maeda Y,Fukayama M,Yamaji T: "Inhibition of growth of human small cell lung cancer by bromocriptine" Cancer Res. 54. 3442-3446 (1994)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-03-09  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi